Vall d'Hebron Institute of Oncology (VHIO)
Marta González Bagà has a diverse work experience in the healthcare and research field. Marta is currently working at the Vall d'Hebron Institute of Oncology (VHIO) as the Lead CRA & Project Manager since 2019. Prior to this, they worked at the same institute as a Clinical Research Associate from 2017 to 2019. In this role, they managed Phase I & II trials, performed site initiation visits and monitoring visits, ensured regulatory compliance, and participated in international teleconferences. Before joining VHIO, Marta worked as a Pharmacy Specialist technician at the Institut Català d'Oncologia (ICO) from 2016 to 2017. Marta also gained experience as a CRA Trainee at Fundació Sant Joan de Déu in 2017, where they conducted clinical trial monitoring and data entry. Marta's earlier experience includes a research internship at Parc Científic de Barcelona from 2014 to 2015, where they worked in the field of developmental neurobiology and neuronal regeneration. Marta also completed a laboratory technician internship at CAP Manso from 2010 to 2011, where they gained experience in clinical diagnostics.
Marta González Bagà has a strong educational background in the field of biomedical sciences and pharmaceutical industry. Marta holds a Bachelor's degree in Biomedical Sciences from the Universitat de Barcelona, which they completed from 2011 to 2015. In 2009 to 2011, they pursued a Superior Technician program in Clinical Diagnostic Laboratory from Ramón y Cajal. Marta also completed a Master's degree in Clinical Trial Monitoring at ESAME - Universitat de Barcelona from 2016 to 2017. In 2018, they attended the VHIO and completed a Clinical Trials in Oncology course. Additionally, they have obtained certifications in Advanced English from Cambridge English Language Assessment in 2013, and DELF A2 from the Ministère chargé de l'Éducation nationale in 2007.
This person is not in any offices
Vall d'Hebron Institute of Oncology (VHIO)
Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO) has established itself as a cancer research center of proven excellence internationally. It is thanks to Josep's directorship and VHIO's optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease. Located within the Vall d´Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d´Hebron University Hospital physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients. VHIO's pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread and more effectively treating even the most undruggable tumour types. VHIO's translation toward precision oncology.